Suven Pharmaceuticals Limited (NSE:SUVENPHAR)
1,131.00
-17.70 (-1.54%)
Apr 29, 2025, 3:30 PM IST
Suven Pharmaceuticals Market Cap
Suven Pharmaceuticals has a market cap or net worth of 292.42 billion as of April 29, 2025. Its market cap has increased by 77.21% in one year.
Market Cap
292.42B
Enterprise Value
286.76B
Revenue
10.48B
Ranking
n/a
PE Ratio
105.07
Stock Price
1,131.00
Market Cap Chart
Since March 9, 2020, Suven Pharmaceuticals's market cap has increased from 33.71M to 292.42B, an increase of 867,482.75%. That is a compound annual growth rate of 483.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 28, 2025 | 292.42B | 0.87% |
Dec 31, 2024 | 289.89B | 57.55% |
Dec 29, 2023 | 184.00B | 46.05% |
Dec 30, 2022 | 125.98B | 0.33% |
Dec 31, 2021 | 125.56B | 9.05% |
Dec 31, 2020 | 115.14B | 341,510.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 4,418.62B |
Divi's Laboratories | 1,599.85B |
Cipla | 1,255.93B |
Mankind Pharma | 1,056.37B |
Apollo Hospitals Enterprise | 1,012.96B |
Zydus Lifesciences | 892.08B |
Aurobindo Pharma | 724.38B |
Alkem Laboratories | 600.91B |